Fig. 1
Patient flow and disposition. Two patients died during screening; three patients died after enrollment, all of whom received four or fewer doses of sebelipase alfa
Fig. 1 | Orphanet Journal of Rare Diseases
Patient flow and disposition. Two patients died during screening; three patients died after enrollment, all of whom received four or fewer doses of sebelipase alfa
Orphanet Journal of Rare Diseases